3-Me-PCE

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

3-Me-PCE
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
Identifiers
  • N-Ethyl-1-(3-methylphenyl)cyclohexanamine
CAS Number
PubChem CID
ChemSpider
E number{{#property:P628}}
CompTox Dashboard (EPA)
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
3D model (JSmol)
  • CCNC1(CCCCC1)c2cc(C)ccc2
  • InChI=1S/C15H23N/c1-3-16-15(10-5-4-6-11-15)14-9-7-8-13(2)12-14/h7-9,12,16H,3-6,10-11H2,1-2H3
  • Key:USOQORZXGGZQGO-UHFFFAOYSA-N

3-Me-PCE is the 3-methyl derivative of the internationally controlled substance Eticyclidine (PCE). It shares structural similarities with 3-MeO-PCE and 3-HO-PCE. 3-Me-PCE first appeared in the scientific literature in 2015 in the context of synthesis and analytical caracterization of a series of arylcyclohexylamines by Wallach et al. It is believed to produce ketamine-like dissociative effects predominantly via antagonism of NMDA receptors.[1] Anecdotal evidence of its efficacy dates back to 2022 and assigns it a potency similar to other PCE analogs.[2] The EUDA issued a notification of its first analytical identification in March 2024.[3]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).